Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy

被引:50
|
作者
Chen, William C. [1 ]
Magill, Stephen T. [2 ]
Wu, Ashley [1 ]
Vasudevan, Harish N. [1 ]
Morin, Olivier [1 ]
Aghi, Manish K. [2 ]
Theodosopoulos, Philip V. [2 ]
Perry, Arie [2 ,3 ]
McDermott, Michael W. [2 ]
Sneed, Penny K. [1 ]
Braunstein, Steve E. [1 ]
Raleigh, David R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA
关键词
atypical meningioma; MIB1; radiation; radiotherapy; oncology; CENTRAL-NERVOUS-SYSTEM; GROSS-TOTAL RESECTION; PROGNOSTIC-FACTORS; RADIATION-THERAPY; ANAPLASTIC MENINGIOMAS; SURGICAL RESECTION; UNITED-STATES; PRIMARY BRAIN; TUMORS; CLASSIFICATION;
D O I
10.3171/2017.9.JNS171609
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The goal of this study was to investigate the impact of adjuvant radiotherapy (RT) on local recurrence and overall survival in patients undergoing primary resection of atypical meningioma, and to identify predictive factors to inform patient selection for adjuvant RT. METHODS One hundred eighty-two patients who underwent primary resection of atypical meningioma at a single institution between 1993 and 2014 were retrospectively identified. Patient, meningioma, and treatment data were extracted from the medical record and compared using the Kaplan-Meier method, log-rank tests, multivariate analysis (MVA) Cox proportional hazards models with relative risk (RR), and recursive partitioning analysis. RESULTS The median patient age and imaging follow-up were 57 years (interquartile range [IQR] 45-67 years) and 4.4 years (IQR 1.8-7.5 years), respectively. Gross-total resection (GTR) was achieved in 114 cases (63%), and 42 patients (23%) received adjuvant RT. On MVA, prognostic factors for death from any cause included GTR (RR 0.4, 95% CI 0.1-0.9, p = 0.02) and MIB1 labeling index (LI) <= 7% (RR 0.4, 95% CI 0.1-0.9, p = 0.04). Prognostic factors on MVA for local progression included GTR (RR 0.2, 95% CI 0.1-0.5, p = 0.002), adjuvant RT (RR 0.2, 95% CI 0.1-0.4, p < 0.001), MIB1 LI <= 7% (RR 0.2, 95% CI 0.1-0.5, p < 0.001), and a remote history of prior cranial RT (RR 5.7, 95% CI 1.3-18.8, p = 0.03). After GTR, adjuvant RT (0 of 10 meningiomas recurred, p = 0.01) and MIB1 LI <= 7% (RR 0.1, 95% CI 0.003-0.3, p < 0.001) were predictive for local progression on MVA. After GTR, 2.2% of meningiomas with MIB1 LI <= 7% recurred (1 of 45), compared with 38% with MIB1 LI > 7% (13 of 34; p < 0.001). Recursive partitioning analysis confirmed the existence of a cohort of patients at high risk of local progression after GTR without adjuvant RT, with MIB1 LI > 7%, and evidence of brain or bone invasion. After subtotal resection, adjuvant RT (RR 0.2, 95% CI 0.04-0.7, p = 0.009) and <= 5 mitoses per 10 hpf (RR 0.1, 95% CI 0.03-0.4, p = 0.002) were predictive on MVA for local progression. CONCLUSIONS Adjuvant RT improves local control of atypical meningioma irrespective of extent of resection. Although independent validation is required, the authors' results suggest that MIB1 LI, the number of mitoses per 10 hpf, and brain or bone invasion may be useful guides to the selection of patients who are most likely to benefit from adjuvant RT after resection of atypical meningioma.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 50 条
  • [1] HISTOPATHOLOGIC FEATURES PREDICT LOCAL CONTROL AFTER ADJUVANT RADIOTHERAPY FOR ATYPICAL MENINGIOMA
    Chen, William
    Magill, Stephen
    Wu, Ashley
    Vasudevan, Harish
    Aghi, Manish
    Theodosopoulos, Philip
    Perry, Arie
    McDermott, Michael
    Sneed, Penny
    Braunstein, Steve
    Raleigh, David
    NEURO-ONCOLOGY, 2017, 19 : 133 - 134
  • [2] The role of adjuvant radiotherapy in atypical meningioma
    Hae Jin Park
    Hyun-Cheol Kang
    Il Han Kim
    Sung-Hye Park
    Dong Gyu Kim
    Chul-Kee Park
    Sun Ha Paek
    Hee-Won Jung
    Journal of Neuro-Oncology, 2013, 115 : 241 - 247
  • [3] ATYPICAL MENINGIOMA: IS ADJUVANT RADIOTHERAPY NECESSARY?
    Waqar, Mueez
    Javadpour, Mohsen
    Barbagallo, Giuseppe M. V.
    McManus, Robin
    Certo, Francesco
    Jenkinson, Michael D.
    NEURO-ONCOLOGY, 2014, 16
  • [4] The role of adjuvant radiotherapy in atypical meningioma
    Park, Hae Jin
    Kang, Hyun-Cheol
    Kim, Il Han
    Park, Sung-Hye
    Kim, Dong Gyu
    Park, Chul-Kee
    Paek, Sun Ha
    Jung, Hee-Won
    JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) : 241 - 247
  • [5] Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
    Zhu, Hongda
    Bi, Wenya Linda
    Aizer, Ayal
    Hua, Lingyang
    Tian, Mi
    Den, Jiaojiao
    Tang, Hailiang
    Chen, Hong
    Wang, Yin
    Mao, Ying
    Dunn, Ian F.
    Xie, Qing
    Gong, Ye
    CANCER MEDICINE, 2019, 8 (01): : 13 - 20
  • [6] Impact of adjuvant radiotherapy in atypical and anaplastic meningioma
    Desideri, Isacco
    Greto, Daniela
    Becherini, Carlotta
    Visani, Luca
    Orsatti, Carolina
    Garlatti, Pietro
    Olmetto, Emanuela
    Cela, Doruntina
    Bertini, Niccolo
    Mangoni, Monica
    Francolini, Giulio
    Bonomo, Pierluigi
    Nozzoli, Filippo
    Peruzzi, Anna
    Carnevale, Maria Grazia
    Della Puppa, Alessandro
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S887 - S889
  • [7] Early adjuvant radiotherapy in the treatment of atypical meningioma
    Jenkinson, Michael D.
    Waqar, Mueez
    Farah, Jibril Osman
    Farrell, Michael
    Barbagallo, Giuseppe M. V.
    McManus, Robin
    Looby, Seamus
    Hussey, Deirdre
    Fitzpatrick, David
    Certo, Francesco
    Javadpour, Mohsen
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 28 : 87 - 92
  • [8] A management dilemma: adjuvant radiotherapy after gross total resection of atypical meningioma
    Fleming, Christopher W.
    Parsai, Shireen
    Suh, John H.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 1 - 3
  • [9] Adjuvant Radiotherapy in Atypical Meningioma: Are the Risks Worth the Benefit?
    Lee, G.
    Aitelli, A.
    Niemierko, A.
    Lamba, N.
    Kim, D. W.
    Chapman, P. H.
    Curry, W.
    Oh, K. S.
    Barker, F. G., II
    Shih, H. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E125 - E125